- Record: found
- Abstract: not found
- Article: not found
Maternity care provider acceptance of a future Group B Streptococcus vaccine – A qualitative study in three countries
Sarah Geoghegan ,
Francia Acosta ,
Laura C. Stephens ,
Hanah Gillan ,
Sandra Valera ,
Richard J. Drew ,
Maeve Eogan ,
Adam J. Ratner ,
Andrew P. Steenhoff ,
Karina M. Butler ,
Kristen A. Feemster
March 2023
March 2023
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
<p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto"
id="d1101552e208">There are vaccines in clinical trials that target the bacterium
Group B Streptococcus
(GBS). When approved, GBS vaccines will be intended for administration to pregnant
women to prevent infection in their infants. The success of any vaccine will depend
on its' uptake in the population. Experience with prior maternal vaccines, e.g. influenza,
Tdap and COVID-19 vaccines, teaches us that acceptance of vaccines, especially if
novel, is challenging for pregnant women, and that provider recommendation is a key
driver of vaccine uptake.
</p>